Showing 1 - 20 results of 40 for search '"Current treating"', query time: 0.11s Refine Results
  1. 1

    Innovation and CSR Impact on Financial Performance of Selected Companies in Mexico by Rocío Durán-Vázquez, Arturo Lorenzo-Valdés, G. Einar Moreno-Quezada

    Published 2012-01-01
    “…Our main interest is to be pioneers in the search for relationships between topics that are currently treated as “alien” (CSR and Innovation) in formal academic publications, but we intuitively know that they are related inside organizations.…”
    Get full text
    Article
  2. 2

    The Role of Cytokines in Postherpetic Neuralgia by Yunyan Shen, Ping Lin

    Published 2025-04-01
    “…PHN is a typical NP and cytokines may induce PHN by promoting central and peripheral sensitization. Currently, treating PHN is challenging and research on the role of cytokine signaling pathways in PHN is lacking. …”
    Get full text
    Article
  3. 3

    Wildfire Smoke Demonstrates Significant and Predictable Black Carbon Light Absorption Enhancements by James E. Lee, Kyle Gorkowski, Aaron G. Meyer, Katherine B. Benedict, Allison C. Aiken, Manvendra K. Dubey

    Published 2022-07-01
    “…The cause of lower‐than‐expected absorption is not well understood and implies a lower radiative impact of BC compared to how many ESMs currently treat aerosols. By analyzing BC aerosol particle‐by‐particle we reconcile observed and expected absorption for ambient smoke plumes varying in geographic origin, fuel types, burn conditions, atmospheric age and transport. …”
    Get full text
    Article
  4. 4

    Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG? by Anne S. De Groot, Leslie Cousens, Federico Mingozzi, William Martin

    Published 2013-01-01
    “…Tregitope applications may include any of the autoimmune diseases that are currently treated almost exclusively with intravenous immunoglobulin G (IVIG), such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN), as well as gene therapy and allergy where Tregitopes may provide a means of inducing antigen-specific tolerance.…”
    Get full text
    Article
  5. 5

    Implementing accessibility in municipal planning: planners’ view by Hanna Wennberg, Agneta Ståhl, Christer Hydén

    Published 2009-09-01
    “…This study investigates how accessibility issues are currently treated in Swedish municipalities in order to examine how older peoples’ accessibility needs are met in daily practice. …”
    Get full text
    Article
  6. 6

    THE VALUE OF THE RUSSIAN NATIONAL REGISTRY OF PATIENTS WITH ANCA-ASSOCIATED SYSTEMIC VASCULITIS AS AN INNOVATIVE TOOL OF PERSONALIZED INDUCTION AND MAINTENANCE THERAPY by T. V. Beketova

    Published 2016-12-01
    “…Nasonova Research Institute of Rheumatology has elaborated a National  Registry of patients with ANCA-SV, which is a regularly updated electronic database for patient follow-up and should be regarded as an innovative personalized induction and maintenance therapy tool that corresponds with the current treat-to-target concept. The main objective of the registry is to permanently  reproduce the goals of therapy for ANCA-SV, as well as to maintain  a sustainable remission, to reduce the incidence of treatment adverse events, to monitor comorbidity,  and to achieve a high quality of life. …”
    Get full text
    Article
  7. 7

    Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History by Marco Lecis, Katia Rossi, Maria Elena Guerzoni, Ilaria Mariotti, Lorenzo Iughetti

    Published 2023-01-01
    “…GAA deficiency is currently treated with enzyme replacement therapy (ERT) with improved clinical outcomes and survival. …”
    Get full text
    Article
  8. 8

    Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits by Lidia Moserle, Roser Pons, Mar Martínez‐Lozano, Gabriela A Jiménez‐Valerio, August Vidal, Cristina Suárez, Enrique Trilla, José Jiménez, Inés de Torres, Joan Carles, Jordi Senserrich, Susana Aguilar, Luis Palomero, Alberto Amadori, Oriol Casanovas

    Published 2020-11-01
    “…Abstract An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. …”
    Get full text
    Article
  9. 9

    Progress in rheumatology in the early 21st century by E. L. Nasonov

    Published 2014-09-01
    “…Substantial progress has been made in the treatment of IIRDs in the 21st century. The current Treat to Target (T2T) strategy for RA is to achieve remission as soon as possible. …”
    Get full text
    Article
  10. 10

    Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial. by Sandor Klis, Ymkje Stienstra, Richard O Phillips, Kabiru Mohammed Abass, Wilson Tuah, Tjip S van der Werf

    Published 2014-03-01
    “…<h4>Background</h4>Buruli Ulcer (BU) is a tropical infectious skin disease that is currently treated with 8 weeks of intramuscular streptomycin and oral rifampicin. …”
    Get full text
    Article
  11. 11

    M.R.H. A New Era in Magnetic Head Design by Mazen R. Husni

    Published 1986-09-01
    “…To write (record) information on the magnetic tape, a modulated current signal is injected into the coil. The current treats (induces) a magnetic field at the free ends of the former (poles) which in turn aligns the magnetic particles deposited on the tape, subsequently producing a record of the injected signal. …”
    Get full text
    Article
  12. 12

    Arthroscopic-Controlled Reduction of Hill-Sachs Lesions: Treatment Option for Off-Track Lesions in Young Patients? by Malte Ohlmeier, M.D., Adrian Schlichter, M.D., Richard Stange, M.D.

    Published 2025-02-01
    “…Large Hill-Sachs lesions (HSL) are currently treated via a remplissage procedure. Although the good stabilizing properties of this surgery are apparent, there are some disadvantages in terms of the functional outcome. …”
    Get full text
    Article
  13. 13

    Studies on <i>Impatiens</i> of Western Himalaya–Rediscovery of <i>Impatiens reidii</i> After Type Collection, Reinstating <i>Impatiens inayatii,</i> and Merging <i>Impatiens scully... by Ashutosh Sharma, Wojciech Adamowski, Syed Noorunnisa Begum

    Published 2025-06-01
    “…., another little-known species described by Hooker as endemic to Kali valley, Kumaon currently treated as a synonym of <i>Impatiens bicornuta</i> Wall., is recollected from near the type locality after 124 years. …”
    Get full text
    Article
  14. 14

    Three-Dimensional Scaffolds Designed and Printed Using CAD/CAM Technology: A Systematic Review by Beatriz Pardal-Peláez, Cristina Gómez-Polo, Javier Flores-Fraile, Norberto Quispe-López, Ildefonso Serrano-Belmonte, Javier Montero

    Published 2024-10-01
    “…Furthermore, the possibility of using the patient’s own stem cells could revolutionize the way bone defects are currently treated in oral surgery. The results indicate a high survival rate of dental implants placed on 3D-printed scaffolds, suggesting the potential of this technology for bone regeneration in the maxillofacial mass.…”
    Get full text
    Article
  15. 15

    BOS-318 treatment enhances elexacaftor–tezacaftor–ivacaftor-mediated improvements in airway hydration and mucociliary transport by Lisa E.J. Douglas, James A. Reihill, S. Lorraine Martin

    Published 2025-02-01
    “…Inhibition of furin therefore, offers a potential therapeutic strategy for those ineligible, intolerant or nonresponsive to ETI and may provide a further opportunity for clinical benefit for those currently treated with ETI. The aim of this study was to determine the impact of furin inhibition on ETI responses to assess its utility as an adjunct therapy. …”
    Get full text
    Article
  16. 16

    Morocco investment case for hepatitis C: using analysis to drive the translation of political commitment to action by Robert Hecht, Miloud Kaddar, Stephen Resch, Jean Luc El Kaim, Chase Perfect, Mustapha Sodqi, Hakima Himmich, Lindsey Hiebert

    Published 2019-03-01
    “…In Morocco, more than 350,000 people are infected with chronic HCV infection yet only 1,500 individuals with mandatory social health insurance are currently treated each year with DAAs. Such treatment coverage is low for this group and is completely inaccessible to the remaining 70% of the population…”
    Get full text
    Article
  17. 17

    Phototherapy for Treating Chronic Spontaneous Urticaria by Zilpa Widyastuti, Triasari Oktavriana

    Published 2025-07-01
    “…The most frequently used medical therapy is second-generation H1 antihistamines followed by first-generation H1 antihistamines. CSU is currently treated with phototherapy utilizing narrowband ultraviolet B (NB-UVB). …”
    Get full text
    Article
  18. 18

    Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias by Heather T. Morgan, Benjamin A. Derman, Hong Ma, Shaji K. Kumar

    Published 2025-04-01
    “…Both diagnoses are currently treated with regimens borrowed from myeloma: a combination of novel agents and chemotherapy induction, then autologous stem cell transplantation (ASCT), with the current practice trending towards consolidation and maintenance. …”
    Get full text
    Article
  19. 19
  20. 20

    The ANZAED Eating Disorder Credential for health care providers: clinician perspectives by Katarina Prnjak, Janet Conti, Madalyn McCormack, Gabriella Heruc, Siân A. McLean, Rebecca Barns, Phillipa Hay

    Published 2025-06-01
    “…Results Credentialed clinicians reported that CPD increased their confidence and willingness to deliver ED treatment, and that supervision enhanced their reflective skills and ethical thinking, whilst 75% of clinicians reported that attaining the Credential had not changed the number of ED patients that they were currently treating on a weekly basis. Content analysis of open-ended questions resulted in three broad themes: professional/personal development; improving care; and acknowledgement and recognition. …”
    Get full text
    Article